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abstract Glycine-124 and leucine-307 of phenylalanine dehy- 
drogenase from Bacillus sphaericus were altered by site-specific 
mutagenesis to the corresponding residues in leucine dehydroge- 
nase: alanine and valine, respectively. These two residues have 
previously been implicated from molecular modelling as impor- 
tant in determining the substrate discrimination of the two en- 
tymes. Single and double mutants displayed lower activities to- 
wards L-phenylalanine and enhanced activity towards almost all 
aliphatic amino acid substrates tested compared to the wild-type, 
thus confirming the predictions made from molecular modelling. 
Key words: Phenylalanine dehydrogenase; Mutagenesis; 
~ubstrate specificity; Amino acids 
I. Introduction 
Phenylalanine dehydrogenase (EC 1.4.1.20) catalyses the re- 
versible NAD+-linked, oxidative deamination of L-phenylalan- 
tne to phenylpyruvate and is found in a limited number of 
Gram-positive, aerobic bacteria [1]. It belongs to a family of 
.amino acid dehydrogenases, whose members include both glu- 
tamate dehydrogenase (EC 1.4.1.2-4) and leucine dehydroge- 
nase (EC 1.4.1.9). Phenylalanine dehydrogenase (PheDH) and 
leucine dehydrogenase (LeuDH) show considerable amino acid 
sequence homology. For example in PheDH from Bacillus 
~phaericus and LeuDH from Bacillus stearothermophilus identi- 
cal residues are found at 50% of the positions [2]. However, the 
substrate specificities of the two enzymes are different. LeuDH 
only accepts aliphatic and not aromatic amino acids as sub- 
strates [3,4]. On the other hand PheDH, besides reacting with 
aromatic amino acids, shows only slight activity towards ali- 
phatic substrates [5,6,7,8]. 
In seeking to decipher the rules governing the activity of 
these enzymes with different substrates, it is now possible to 
compare their amino acid sequences in the light of the known 
structure of glutamate dehydrogenase (GDH) from Clostridium 
~ymbiosum [2,9-11]. Though the sequences of both PheDH and 
LeuDH show a relatively low level of sequence identity with 
GDH, the alignment suggests that residues inferred as being 
responsible for the overall shape of the active site and for 
catalysis, as well as those involved in the recognition of the 
nicotinamide cofactor, are conserved in all three enzymes 
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[2,12]. This justifies the attempt o model the structure of the 
amino acid dehydrogenases u ing the GDH structure as a 
framework [2]. Glycine-124 and leucine-307 in PheDH (num- 
bering based on the B. sphaerieus sequence; the corresponding 
residues in Clostridium symbiosum GDH are 163 and 377, re- 
spectively) are replaced by alanine and valine, respectively, 
both in LeuDH [2] and in another branched-chain amino acid 
dehydrogenase, valine dehydrogenase from Streptomyces coeli- 
color [13]. It appears that in PheDH the glycine and leucine 
residues at these two positions allow the access of a large planar 
aromatic substrate into the binding pocket (Fig. 1). 
In this paper we describe the substitution of glycine-124 and 
leucine-307 in the PheDH sequence of Bacillus sphaericus for 
alanine and valine, respectively, by site-directed mutagenesis. 
The resultant mutants how decreased activity towards L-phen- 
ylalanine and increased catalytic activity towards most ali- 
phatic amino acid substrates tested. 
2. Materials and methods 
2.1. Materials 
Restriction enzymes, T4 DNA ligase and calf intestinal alkaline 
phosphatase w re from Northumbrian Biologicals (UK). Reagents for 
site-directed mutagenesis were supplied in a kit by Boehringer Corp. 
(Lewes, UK). DNA sequencing was performed using the 7-deaza-dGTP 
kit and Sequenase Version 2.0 (United States Biochemicals, USA). 
Plasmid DNA was prepared by using the Wizard miniprep from 
Promega Corp. (USA). The Geneclean II Kit was obtained from BIO 
101 (La Jolla, CA, USA). Oligonucleotides for mutagenesis were syn- 
thesised by Dr. A.J.G. Moir and Mr. P.E. Brown (University of Shef- 
field) using an Applied Biosystems 381A DNA synthesiser. Oligonucle- 
otides for DNA sequencing were synthesised using the Cyclone Plus 
DNA synthesizer (Milligen, USA). Sepharose CL-6B and butyl-Sepha- 
rose 4 fast flow were from Pharmacia Biotech (UK). Procion red P3BN 
was from Imperial Chemical Industries (UK). All other chemicals were 
of analytical grade. 
2.2. Bacterial strains and plasmids 
Escherichia coli TG1 (Alac-proAB, supE, thil, hsdA5/F'traD36, 
proA+B +, lacI q, lacZAM15) and CJ236 (dutl, ungl, thil, relA llpCJ lO59- 
(cmr)) were obtained from Boehringer Corp, (Lewes, UK). E. coli strain 
containing plasmid pBDH 1DBL (pdh gene of B. sphaericus inserted in 
the BamH 1 site of pUC8) was provided by Sagami Chemical Research 
Centre (Kanagawa, Japan). M13mpl9 was purchased from Pharmacia 
Biotech (UK). The plasmid ptac85 [15] was used to express the wild- 
type and mutant pdh genes. 
2.3. Plasmid construction and mutagenesis 
The wild-type and mutant pdh genes were subcloned into the BamH 1 
site of M13mpl9 and into ptac 85 using standard procedures [16]. The 
orientation ofthe gene in the plasmid was determined by EcoRI digests 
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since there are two asymmetrically positioned EcoRI sites in the pdh 
gene. The mutagenic oligonucleotides 5'-TTTACACAGCTACTGAC- 
AT-3' (the underlined codon GCT replacing GGT) and 5'-GCCGG- 
CGGCGTGATCCAG-Y (the underlined codon GTG replacing TTG) 
were used to create the G 124A and L307V mutations, respectively. The 
mutagenic oligonucleotides were hybridised to the antisense strand and 
mutants were preferentially selected by using the uracilated-DNA tem- 
plate method [17,18]. Mutants were screened irectly by sequencing 
using the dideoxy-chain termination method. [19]. The entire DNA 
sequences of the selected positive mutants were then determined to 
confirm that there were no other secondary mutations. The mutant 
genes were cloned into the expression vector ptac85, the genes of the 
positive clones were recloned back into M13mp19, and the entire DNA 
sequences were again determined to confirm that no other mutations 
had occurred uring the cloning procedure. 
2.4. Expression and purification of enzymes 
The wild-type and mutant pdh genes were expressed under control 
of the tac promoter of ptac85. Potassium phosphate buffer, pH 7.9, 
containing 0.1 mM EDTA and 5 mM 2-mercaptoethanol, was used 
throughout the purification procedure which was carried out at room 
temperature unless indicated otherwise. 
E. coli TG1 cells containing the expression plasmid were grown in 
LB medium supplemented with 0.1 mg/ml ampicillin at 37°C. 0.5 mM 
of isopropyl fl-D-thiogalactopyranoside was added to the culture in log 
phase and the culture was allowed to grow for a further 3 h before 
harvesting. The harvested cell pellet was resuspended in 0.1 M phos- 
phate buffer and broken by sonication. Cell debris was removed by 
centrifugation at 20000 x g for 30 min. The clarified supernatant was 
brought o 30% ammonium sulphate saturation to remove unwanted 
proteins. The resultant soluble proteins were then brought to 60% 
ammonium sulphate saturation. The precipitate was dissolved in 0.01 M 
phosphate buffer and dialysed against three changes of 0.01 M 
phosphate buffer at 4°C before applying to a Procion red P3BN column 
(12 x4 cm prepared by immobilising the dye on Sepharose CL-6B 
according to a standard procedure [20]). Unbound materials were 
washed off the column with 0.01 M phosphate buffer and the enzyme 
was eluted with 0.2 M NaC1 dissolved in the same buffer. The eluate 
was brought o 30% saturation with ammonium sulphate and loaded 
onto a butyl-Sepharose column (5 x 2 cm) pre-equilibrated with 30% 
ammonium sulphate in 0.01 M buffer. Unbound proteins were washed 
off with the pre-equilibration solution. The enzyme was eluted with 20% 
saturation of ammonium sulphate in 0.01 M phosphate buffer and 
stored as a precipitate in 60% ammonium sulphate. Before use, the 
enzyme was pelleted by centrifugation, redissolved in0.01 M phosphate 
buffer and dialysed against he same buffer to remove all traces of 
ammonium sulphate. The concentration of the purified enzyme was 
determined by measuring its absorbance at280 nm, using an extinction 
coefficient of 11.7 x 10 -; absorbance units • g-1. ml • cm -~ [6]. The pu- 
rity of the enzyme was routinely monitored by SDS-PAGE according 
to the discontinuous method of Laemmli [21]. 
2.5. Enzyme assay 
The enzyme activity was determined at25°C spectrophotometrically 
(Kontron Uvikon 941 plus) by measuring the reduction ofNAD ÷ at 340 
nm in a 1-cm cuvette. Reaction mixtures (1 ml) contained 50/xmol 
glycine-KOH buffer, pH 10.4, 100/2mol KC1, 2.5 pmol NAD ÷, 10/.tmol 
of the amino acid substrate and the appropriate amount of enzyme. One 
unit of enzyme activity was the amount hat catalysed the formation 
of 1/2mol NADH/min. 
3. Results and discussion 
3.1. Construction of  mutants 
Using a mixture of the two mutagenic oligonucleotides, 
about 50% of the putative mutants screened contained the 
double mutat ion G 124A;L307V, while the other 50% contained 
only the L307V mutation. Surprisingly, the G124A single mu- 
tant was not obtained using the mixture of oligonucleotides nor 
with the single oligonucleotide. This single mutant  was finally 
constructed by ligating an Avail fragment containing the 
G124A mutat ion of the double mutant  gene to the AvaII flag- 
ment of the wild-type pdh gene containing the wild-type se- 
quence at position 307. 
Sequencing of the entire gene in the three mutants confirmed 
the presence of the desired mutations. There were, however, 
three positions that were not consistent with the published 
sequence [22]. The two codons for Asp-240 and Asp-241 were 
found to be GAT and GAC instead of GAC and GAT. The 
putative - 35 sequence of the pdh gene was found to be TTGAT 
instead of TTGAAT. These differences in sequence were not 
introduced in the site-directed mutagenesis procedure since the 
wild-type gene sequence was found to show the same difference. 
At  present it is not clear whether this is due to mutat ions 
occurring in the cloned gene or an error in the published se- 
?) 
Fig. 1. A MOLSCRIPT [14] diagram of the modelled side chain speci- 
ficity pocket for phenylalanine in the PheDH from Z intermedius. For 
ease of comparison, the clostridial GDH numbering is retained here. 
The positions subjected to mutagenesis in this paper (boxed in the 
figure), glycine-124 and leucine-307 inB. sphaerieus PheDH are glycine- 
163 and valine-377 in the clostridial GDH sequence and alanine and 
valine in LeuDH. PheDH from Thermoactinomyces intermedius i used 
in this modelling exercise. The residues depicted in this diagram are 
essentially the same as the PheDH from B. sphaericus except hat A193 
in T. intermedius i replaced by N in B. sphaericus. The ribbon repre- 
sents the fold of the polypeptide chain. The coordinates of C symbio- 
sum GDH [12] were used to provide the molecular framework of the 
binding pocket with the side chains modified to take into account of 
the sequence changes between GDH and PheDH. The strongly con- 
served side chains in the GDH family which are retained in the PheDH 
sequence are shown in a ball and stick representation whilst hose which 
are modified in the PheDH sequence are portrayed in a solid chain style 
and reduced size labelling. The nicotinamide ring of the NAD, in the 
bottom left of the picture, and the modelled location of the bound 
phenylalanine substrate, in the centre, are portrayed in solid chain. The 
water molecule, OWl, thought o be the attacking nucleophile in the 
catalytic ycle, is shown as a sphere. 
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quence. These differences in sequence are however not expected 
to alter the enzyme since the encoded sequence is unaltered. 
3.2. Expression and purification of wild-type and mutant enzyme 
The mutant and wild-type pdh genes were highly expressed 
in E. coli TG 1. A litre of culture yielded about 30 mg of PheDH 
estimated to be at least 99% pure as shown in Fig. 2. 
The specific activity of the recombinant wild-type enzyme 
purified t¥om E. coli was determined to be about 87 U/rag. 
3.3. Relative activities towards' different substrates 
The mutant enzymes were tested for activity on a variety of 
substrates. The specific activities expressed as a percentage of 
the activity for L-phenylalanine are shown in Table 1. 
Both single and double mutants howed a marked decrease 
in activities towards the aromatic substrates, L-phenylalanine 
and L-tyrosine, compared to the wild-type nzyme. The specific 
activities of the single mutant G124A and double mutant 
G124A;L307V were decreased about 20-fold for e-phenylalan- 
ine and 200-fold for L-tyrosine. This could be attributed to the 
fact that the methyl side chain of alanine is in a position that 
interferes with the aromatic-ring sterically [2]. The presence of 
an additional hydroxyl group attached to the aromatic ring 
might increase this steric hindrance, thus explaining the fact 
that a greater eduction in activity was observed for L-tyrosine 
compared to k-phenylalanine in these mutants. The reduction 
in activities for aromatic substrates in the case of the L307V 
mutant could be attributed to the fact that the leucine residue 
at position 307 of PheDH is probably responsible for hydro- 
phobic interaction with the aromatic side chain of the phenyl- 
alanine substrate. Substitution ofleucine-307 by valine, an amino 
acid with a shorter side chain, might decrease the strength of 
this interaction, thus reducing overall activity. 
In the two mutants containing the change G124A, the activ- 
ities towards aliphatic amino acid substrates were enhanced 
compared to the wild-type. The most striking example of this 
is for L-isoleucine where the activity is increased 22-fold in the 
double mutant. Combined with the accompanying opposite 
change in activity towards k-phenylalanine, this corresponds to
k~ 1 2 3 4 5 
66.0=.  
45 .0=-  
34 .7=-  
24 .0  =-  
18,4 =-  
14 .3  =-  
Fig. 2. SDS-PAGE of purified wild-type and mutant PheDH enzymes 
Lane 1 -- molecular weight markers: bovine albumin (66000 Da), egg 
albumin (45000 Da), porcine stomach mucosa pepsin (34700 Da), bo- 
vine pancreas PMSF-treated trypsinogen (24000 Da), bovine milk fl- 
lactoglobulin (2 subunits ~18400 Da), chicken egg white lysozyme 
(14300 Da); Lane 2 = wild-type PheDH; Lane 3 = G124A; Lane 
4 = L307V; Lane 5 = G124A;L307V. 
a 380-fold decrease in the discrimination between these two 
substrates. In addition, the activities for L-isoleucine and 
L-norleucine are higher than for L-phenylalanine in the double 
mutant. Thus, two rather conservative amino acid substitutions 
are sufficient o transform a phenylalanine dehydrogenase of 
narrow substrate specificity into an enzyme with an apparent 
preference for certain aliphatic substrates. 
The single mutation L307V produces a substantial decrease 
in the rates measured with k-phenylalanine and L-tyrosine as 
substrates, but normally no change in the rates for the straight- 
chain aliphatic substrate L-norvaline, L-norleucine and 
L-methionine. On the other hand with branched-chain substrates 
there was an increase for amino acids with a ]~-branch (L-valine 
and L-isoleucine) and a 4-fold decrease for L-leucine, with a 
?'-branch. 
Attempts have previously been made to change the substrate 
specificity of PheDH from Thermoactinomyces intermedius. 
The conserved amino acid residues t24F-V-H-A-A-~-~'~R of this 
PheDH (corresponding to residues 134-139 in the B. sphaericus 
enzyme) have been replaced by M-D-M-Y-Q, the correspond- 
ing sequences in LeuDH of B. stearothermophilus [23]. Al- 
though substrate discrimination of the resultant enzyme was 
altered, the catalytic efficiency towards all the amino acid sub- 
strates was reduced. The altered specificity is the result of the 
greater eduction in the catalytic efficiency of this enzyme to- 
wards L-phenylalanine rather than a positive selection for ali- 
phatic substrates. A chimaeric enzyme made up of the N-termi- 
nus of PheDH from Thermoactinomyces intermedius and the 
C-terminus of LeuDH of Bacillus stearothermophilus have also 
been constructed [24]. The resultant enzyme has a glycine cor- 
responding to position 124 and a valine corresponding to posi- 
tion 307. The activity of this enzyme towards L-isoleucine and 
k-valine was higher than the wild-type Thermoactinomyces in- 
termedius PheDH, while e-leucine gave a lower activity. This 
result was consistent with the L307V mutant obtained here. The 
valine residue at position 307 probably had an important effect 
in the chimaeric enzyme. However, other residues might also 
be important since in the case of k-norvaline and L-norleucine, 
a much lower activity was obtained in the chimaeric protein, 
while the L307V mutant obtained here has a similar activity for 
L-norvaline and k-norleucine compared to the wild-type en- 
zyme. 
The sequences of LeuDH from Thermoactinomyces interme- 
dius [25] and PheDH of Rhodococcus sp. M4 [26] have become 
available recently. As expected, the LeuDH from T. intermedius 
has an alanine and a valine corresponding to position 124 and 
307 in the B. sphaericus PheDH enzyme, similar to the B. 
stearothermophilus LeuDH used in the molecular modelling. 
In the Rhodococcus PheDH, however, the residue correspond- 
ing to position 124 is glycine but position 307 is alanine rather 
than leucine as seen in B. sphaericus and T. internwdius. The 
effect of this difference is not yet certain because data for the 
relative activities of the Rhodococcus enzyme towards aliphatic 
substrates are not available. However, on the basis of the result 
presented here, we anticipate that this will result in a modified 
specificity profile towards aliphatic substrates. Further analysis 
of the Rhodococcus sequence shows a number of other changes 
in the substrate binding pocket with respect o B. sphaericus, 
namely leucine-36, phenylalanine-113 and leucine-314, which 
are replaced by alanine, asparagine and valine, respectively, in
the Rhodococcus sequence. We predict that these differences 
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Table 1 
Relative activities of wild-type and mutant PheDH with various aromatic and aliphatic substrates 
Amino acids Wild-type L307V G124A G124A;L307V 
1 2 1 2 1 2 
L-Phenylalanine 100 27 100 4.6 100 5.7 100 
L-Tyrosine 75 23 85 0.36 7.8 0.42 7.4 
L-Leucine 1.1 0.22 0.81 2.6 57 2.5 44 
L-Isoleucine 0.38 0.86 3.2 4.1 89 8.6 151 
L-Norleucine 3.7 3.7 13 4.0 87 6.8 119 
L-Valine 1.4 2.0 7.4 2.4 52 4.2 74 
L-Norvaline 1.7 1.6 6.0 3.7 80 3.5 61 
L-Methionine 2.2 2.0 7.4 3.1 67 2.8 49 
For the wild-type nzyme, activity is expressed as a percentage of activity towards L-phenylalanine. For the mutants, column 1 shows the activity 
expressed as a percentage of the wild-type activity towards L-phenylalanine, while column 2 shows activity expressed as a percentage of the activity 
of each individual enzyme towards L-phenylalanine. The concentration of substrate used in each case is 10 mM except for L-tyrosine, where a 
concentration of 3 mM was used instead. 
will have additional bearing on the substrate preferences of this 
enzyme. 
In one respect, the predictions of the modelling are not fully 
borne out, i.e. LeuDH from various sources does indeed display 
a broad specificity for amino acids with non-polar side chains, 
but none of the LeuDH reported shows activity with phenyl- 
alanine. In the mutants produced here, L-phenylalanine r mains 
as a substrate. This implies that there are other sequence differ- 
ences between PheDH and LeuDH which make additional con- 
tributions to their substrate specificities. 
Further studies will now be required to establish the extent 
to which the observed changes reflect altered Km values as 
opposed to possible changes in maximum catalytic rate. 
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